🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Linxi Zhu

Wenzhou University

ORCID: 0000-0003-0204-6849

Also affiliated with University of Washington, Nanjing Drum Tower Hospital, Nano Carbon (Poland)

MedicineMaterials Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “ICAM-1 Targeted Drug Combination Nanoparticles Enhanced Gemcitabine-Paclitaxel Exposure and Breast Cancer Suppression in Mouse Models”.

ICAM-1 Targeted Drug Combination Nanoparticles Enhanced Gemcitabine-Paclitaxel Exposure and Breast Cancer Suppression in Mouse Models

Pharmaceutics(2021)10.3390/pharmaceutics14010089
N/A
0.442DataRank · unranked
18 citations

Qingxin Mu, Jesse Yu, James I. Griffin, Xiaolin Xu, Rodney J. Y. Ho +1 more

Novel drug combination nanoparticles exhibit enhanced plasma exposure and dose-responsive effects on eliminating breast cancer lung metastasis

PLoS ONE(2020)10.1371/journal.pone.0228557
N/A
0.396DataRank · unranked
13 citations

Jesse Yu, James I. Griffin, Yan Wu, Linxi Zhu, Lisa A. McConnachie +2 more

Systems and Clinical Pharmacology of COVID-19 Therapeutic Candidates: A Clinical and Translational Medicine Perspective

Journal of Pharmaceutical Sciences(2020)10.1016/j.xphs.2020.11.019
N/A
0DataRank · unranked
20 citations

Linxi Zhu, Weixian Lin, Alexander Nguyen, Rodney J. Y. Ho, Simone Perazzolo

Challenges and opportunities in metastatic breast cancer treatments: Nano-drug combinations delivered preferentially to metastatic cells may enhance therapeutic response

Pharmacology & Therapeutics(2022)10.1016/j.pharmthera.2022.108108
N/A
0DataRank · unranked
97 citations

Qingxin Mu, Millie Fung, Xiaolin Xu, Linxi Zhu, Rodney J. Y. Ho +1 more